Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ
518.58
-6.41(-1.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
518.58
-6.41(-1.22%)
Currency In USD
| Market Cap | 13.06B |
| Enterprise Value | 13.22B |
| P/E Ratio | -40.36 |
| PEG Ratio | -37.5 |
| Price/Sales Ratio | 12.41 |
| Price/Book Ratio | 19.3 |
| Enterprise/Revenue | 12.57 |
| Enterprise/EBITDA | -45.57 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.3 |
| Operating Margin | -0.31 |
| Return On Assets | -0.23 |
| Return On Equity | -0.44 |
| Revenue | 958.4M |
| Revenue/Share | 42.72 |
| Gross Profit | 902.26M |
| EBITDA | -264.47M |
| Net Income | -288.28M |
| Diluted EPS | -12.85 |
| Total Cash | 983.56M |
| Total Cash/Share | 43.84 |
| Total Debt | 354.36M |
| Total Debt/Equity | 0.59 |
| Current Ratio | 4.01 |
| Book Value Per Share | 26.86 |
| 52-Week Change | 61.5 |
| 52-Week High | 615 |
| 52-Week Low | 265 |
| Moving Average 50 Days | 470.81 |
| Moving Average 200 Days | 455.24 |
| Average Volume | 367,123 |
| Shares Outstanding | 22.94M |
| % Held by Institutions | 104.83 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | July 25, 2016 |